Regarding molecular subtypes, TN cancer exhibited the highest correct estimation rate (each 97.2%, reader 1; 100% and 97.2%, reader 2), while HER-2 cancer groups showed the lowest correct estimation rate (48.0% and 52.0%, reader 1 and 2, respectively). Here, ERBB2 is linked to cancer.